Amgen | Créances Commerciales



Trade Debtors Changement Date
AbbVie USD 12.48B 1.56B 2025-03
Agios Pharmaceuticals USD 3.34M 765K 2025-03
ALKERMES USD 356.33M 34.58M 2025-06
Amgen USD 8.13B 1.35B 2025-03
Biogen USD 2B 127.7M 2025-03
BioMarin Pharmaceutical USD 739.18M 78.64M 2025-03
Bristol-Myers Squibb USD 15.1B 515M 2025-06
Eli Lilly USD 14B 727.8M 2025-03
Exelixis USD 292.35M 10.72M 2025-07
Genmab DKK 799M 5.89B 2025-03
Gilead Sciences USD 4.39B 32M 2025-03
GlaxoSmithKline GBP 7.5B 176M 2025-03
Glaxosmithkline GBP 7.32B 542M 2024-12
Incyte USD 842.89M 19.76M 2025-06
Ionis Pharmaceuticals USD 39.71M 52.48M 2025-03
J&J USD 16.02B 1.18B 2025-03
Merck USD 11.57B 452M 2025-03
Moderna USD 306M 286M 2025-03
Neurocrine Biosciences USD 516M 36.9M 2025-03
Novartis USD 9.18B 451M 2025-06
Novartis USD 7.56B 594M 2024-12
Pfizer USD 14.74B 32M 2025-03
PTC Therapeutics USD 210.5M 51.94M 2025-03
Regeneron Pharmaceuticals USD 5.56B 650.9M 2025-03
Roche Holding CHF 13.46B 984M 2024-12
Sanofi 447M 10.18B 2025-03
Sarepta Therapeutics USD 724.52M 74.8M 2025-03
Takeda JPY 679.53B 45.72B 2025-06
Teva Pharmaceutical Industries USD 3.38B 325M 2025-03
Ultragenyx Pharmaceutical USD 123.6M 28.5M 2024-12
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12


Amgen Créances Commerciales - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.